These guides are AI-generated educational summaries — not legal or medical advice.
C&P Exam Prep: Tuberculosis (Pulmonary / Non-Pulmonary)
DBQ Overview
Interview + Physical- Form Name
- Tuberculosis
- Form Code
- Tuberculosis
- Page Count
- 7
- Examiner Type
- Pulmonologist or Infectious Disease Physician
- Estimated Duration
- 30-45 minutes
- Exam Format
- Interview + Physical
What to Expect During Your Exam
Exam Overview
To document the current severity, activity status, extent of pulmonary or non-pulmonary involvement, residual functional impairment, and service connection nexus for tuberculosis under 38 CFR 4.97 and 4.88. The examiner will determine whether TB is active or inactive, the degree of lesion advancement, presence of complications, and impact on daily functioning and employability.
What the examiner evaluates:
- Whether tuberculosis is currently active or inactive (arrested)
- Degree of lesion advancement: minimal, moderately advanced, or far advanced
- Pulmonary function test results (FEV1, FVC, FEV1/FVC ratio, DLCO)
- Presence and severity of respiratory symptoms: dyspnea on exertion, chronic cough, hemoptysis, wheezing
- Pulmonary complications: emphysema, pulmonary hypertension, right ventricular hypertrophy, cor pulmonale, acute respiratory failure
- Non-pulmonary TB manifestations: skeletal TB, genitourinary TB, gastrointestinal TB, tuberculous meningitis, tuberculous pleurisy, tuberculous peritonitis, tuberculous laryngitis, tuberculous lymphadenitis, cutaneous TB, ocular TB
- Treatment history: medications used, dates of treatment initiation and completion
- Imaging findings: chest X-ray, CT scan, high-resolution CT (HRCT), MRI results
- Scar tissue, cavitation, fibrosis, or calcification visible on imaging
- Whether the condition causes impairment of health or functional limitations
- Any secondary or associated conditions caused or aggravated by TB
- Impact of the condition on occupational and daily activities
The examination typically occurs at a VA medical center, VAMC affiliate, or contracted QTC/LHI/Optum Serve clinic. Bring all prior imaging CDs or reports, pulmonary function test records, treatment records, and any private physician statements. You have the right to record the exam in most states - check your state law and notify the examiner beforehand. The examiner will review medical records, conduct a respiratory-focused physical exam, and may order or review spirometry results.
Typical duration: 30-45 minutes
FEV1 (Forced Expiratory Volume in 1 Second)
The volume of air you can forcefully exhale in the first second of a breath. A primary indicator of obstructive lung disease and overall respiratory capacity. Used directly to assign rating percentages under 38 CFR 4.97.
What to expect:
You will be asked to breathe in deeply and then blow out as hard and fast as possible into a mouthpiece connected to a spirometer. At least three acceptable efforts are required. Pre- and post-bronchodilator measurements may be taken. The test takes approximately 15-20 minutes.
Key thresholds:
- FEV1 > 70% of predicted — Supports lower severity ratings; may result in 0% if asymptomatic residuals
- FEV1 56-70% of predicted — Supports 30% rating range for chronic pulmonary residuals
- FEV1 40-55% of predicted — Supports 60% rating range for chronic pulmonary residuals
- FEV1 < 40% of predicted — Supports 100% rating for severe chronic pulmonary residuals
- Active TB (any severity) — Automatic 100% while active under DC 6702, 6703, or 6704
Tips:
- Do NOT use bronchodilators, inhalers, or caffeine for the specified period before testing - follow your provider's instructions
- Wear loose clothing; do not eat a heavy meal within 2 hours of testing
- If you experience significant shortness of breath, dizziness, or chest tightness during the test, stop and notify the technician immediately
- Give maximum effort on every attempt - inconsistent effort can result in artificially low or high readings
- If your condition is worse on some days due to weather, allergens, or exertion, mention this to the examiner so the single-day result is contextualized
- Ask the examiner to document if you were symptomatic or fatigued during testing
Pain considerations: Forceful exhalation may trigger coughing episodes, chest discomfort, or pain in veterans with pleuritic involvement or post-surgical scarring. Notify the examiner if forceful exhalation causes pain or coughing that limits your best effort - this functional limitation itself is relevant evidence.
FVC (Forced Vital Capacity)
Total volume of air exhaled during a forced breath. Reduction in FVC indicates restrictive lung disease, which is common in TB-related fibrosis, pleural scarring, and post-cavitary lesions.
What to expect:
Measured during the same spirometry session as FEV1. Results are expressed as a raw volume (liters) and as a percentage of predicted value based on age, height, sex, and ethnicity.
Key thresholds:
- FVC - 80% predicted — Normal range; supports lower severity unless other indicators present
- FVC 51-79% predicted — Mild to moderate restriction; supports intermediate rating levels
- FVC - 50% predicted — Severe restriction; supports higher rating levels
Tips:
- FVC reduction combined with FEV1 reduction strengthens the case for higher severity ratings
- Mention if your breathing capacity varies day to day or worsens with exertion, cold air, or illness
- TB-related pleural scarring and fibrosis often cause restriction even after the infection is resolved - make sure the examiner understands this connection
Pain considerations: Pleuritic chest pain or musculoskeletal pain from past thoracic surgery or rib involvement may limit maximum inhalation and exhalation effort. Clearly communicate any pain that prevents you from inhaling fully.
FEV1/FVC Ratio
The ratio of FEV1 to FVC. Used to distinguish obstructive (e.g., emphysema, COPD) from restrictive (e.g., fibrosis) patterns. TB can cause both patterns depending on extent of destruction and scarring.
What to expect:
Automatically calculated from spirometry data. A ratio below 0.70 suggests obstruction; a preserved or elevated ratio with reduced FVC suggests restriction.
Key thresholds:
- FEV1/FVC < 0.70 — Obstructive pattern; consistent with TB-related emphysema or bronchiectasis
- FEV1/FVC - 0.70 with reduced FVC — Restrictive pattern; consistent with TB-related fibrosis or pleural disease
Tips:
- Ensure the examiner documents both the pre- and post-bronchodilator values if available
- TB-related obstructive patterns are ratable as respiratory residuals under 38 CFR 4.97
Pain considerations: Not typically painful; however, forceful breathing maneuvers may exacerbate pleuritic or chest wall discomfort.
DLCO (Diffusing Capacity of the Lungs for Carbon Monoxide)
Measures how efficiently the lungs transfer gas from inhaled air to the bloodstream. Reduced DLCO indicates damage to the alveolar-capillary membrane, common in TB-related fibrosis and emphysema.
What to expect:
You will inhale a small amount of carbon monoxide mixed with other gases, hold your breath for 10 seconds, then exhale. The exhaled gas is analyzed. Results expressed as percent predicted.
Key thresholds:
- DLCO - 70% predicted — Near normal gas exchange; lower severity
- DLCO 41-69% predicted — Moderate impairment; supports intermediate to higher ratings
- DLCO - 40% predicted — Severe impairment; supports 100% rating range
Tips:
- Do not smoke for at least 4 hours before the DLCO test as carbon monoxide from smoking artificially lowers the result
- DLCO reduction documents the real-world functional impact of lung tissue destruction even when spirometry appears near-normal
- Ask the examiner to include DLCO results in the DBQ even if only spirometry was ordered
Pain considerations: Breath-holding is required; if chest pain or coughing prevents adequate breath-holding, inform the technician.
Rating Criteria Breakdown
| Rating % | Criteria | Key Symptoms |
|---|---|---|
| 100% | Active tuberculosis of any variety - pulmonary or non-pulmonary - regardless of degree of advancement. Under DC 6702 (moderately advanced active), DC 6703 (minimal active), and DC 6704 (advancement unspecified active), active TB is rated at 100% for the duration of activity. Additionally, per 38 CFR 4.88b, inactive pulmonary TB that was far advanced at any time is initially rated 100% for two years following inactivity, then reduced to 50% and again to 30% per the staged reduction schedule. Non-pulmonary TB forms such as meningitis, skeletal TB, genitourinary TB, and others are rated at 100% while active. |
CFR: 38 CFR 4.97 DC 6702: Tuberculosis, pulmonary, chronic, moderately advanced, active - 100%. DC 6703: Tuberculosis, pulmonary, chronic, minimal, active - 100%. DC 6704: Tuberculosis, pulmonary, chronic, active, advancement unspecified - 100%. M21-1 V.iii.4.B: Active TB is rated 100% for the duration of active disease regardless of advancement level. |
| 100% | Inactive (arrested) pulmonary TB that was far advanced at any time during the disease course. Under 38 CFR 4.88b and M21-1 V.iii.4.B.2, the veteran receives a 100% rating for two full years from the date of inactivity. This is the initial stage of the staged reduction schedule even after bacteriological cure. |
CFR: DC 6721: Tuberculosis, pulmonary, chronic, far advanced, inactive. M21-1 Example: Far advanced inactive TB rated 100% from date of inactivity, 50% two years later, 30% four years after inactivity date per staged reduction schedule. |
| 50% | Inactive (arrested) pulmonary TB with far-advanced lesion history, two years after the date of inactivity under the staged reduction schedule per 38 CFR 4.88b. Also applicable to inactive TB with moderately advanced residual damage that produces significant but not total functional impairment as rated under the residual respiratory conditions framework. |
CFR: M21-1 V.iii.4.B.3: Far advanced inactive TB reduced to 50% two years after date of inactivity. M21-1 Example 3: Reduction to 50% effective date of last payment at expiration of due process period. |
| 30% | Inactive (arrested) pulmonary TB with far-advanced lesion history, four years after the date of inactivity under the staged reduction schedule per 38 CFR 4.88b. Also applicable to inactive TB residuals with mild-to-moderate functional impairment rated under associated respiratory diagnostic codes. |
CFR: M21-1 V.iii.4.B.3: Far advanced inactive TB reduced to 30% four years after date of inactivity. M21-1 Example 4: Staged reduction to 30% four years after date of reinstatement following reexamination. |
| 0% | Inactive TB with minimal or no residual functional impairment. Spirometry near normal, no significant respiratory symptoms, no complications, and no ongoing treatment requirement. However, a 0% rating still establishes service connection, preserving eligibility for future increases if condition worsens or complications develop. |
CFR: Residual respiratory ratings under 38 CFR 4.97; 0% rating applies when TB is inactive with no compensable residuals. Service connection should still be established. |
100% Active tuberculosis of any variety - pulmonary or non-pulmon ...
Active tuberculosis of any variety - pulmonary or non-pulmonary - regardless of degree of advancement. Under DC 6702 (moderately advanced active), DC 6703 (minimal active), and DC 6704 (advancement unspecified active), active TB is rated at 100% for the duration of activity. Additionally, per 38 CFR 4.88b, inactive pulmonary TB that was far advanced at any time is initially rated 100% for two years following inactivity, then reduced to 50% and again to 30% per the staged reduction schedule. Non-pulmonary TB forms such as meningitis, skeletal TB, genitourinary TB, and others are rated at 100% while active.
Key Symptoms
- Bacteriologically confirmed active TB (sputum culture, AFB smear, NAAT positive)
- Constitutional symptoms: fever, night sweats, significant weight loss, fatigue
- Hemoptysis
- Progressive cough with productive sputum
- Radiographic evidence of active cavitation, consolidation, or miliary pattern
- Currently on anti-TB treatment regimen (RIPE therapy or equivalent)
- Failure to complete treatment or drug-resistant TB requiring extended therapy
- Non-pulmonary active TB: meningitis, skeletal, genitourinary, GI, pleural involvement
CFR: 38 CFR 4.97 DC 6702: Tuberculosis, pulmonary, chronic, moderately advanced, active - 100%. DC 6703: Tuberculosis, pulmonary, chronic, minimal, active - 100%. DC 6704: Tuberculosis, pulmonary, chronic, active, advancement unspecified - 100%. M21-1 V.iii.4.B: Active TB is rated 100% for the duration of active disease regardless of advancement level.
100% Inactive (arrested) pulmonary TB that was far advanced at an ...
Inactive (arrested) pulmonary TB that was far advanced at any time during the disease course. Under 38 CFR 4.88b and M21-1 V.iii.4.B.2, the veteran receives a 100% rating for two full years from the date of inactivity. This is the initial stage of the staged reduction schedule even after bacteriological cure.
Key Symptoms
- Prior documentation of far-advanced lesions on imaging
- Bilateral or extensive pulmonary involvement
- Severe respiratory impairment even after completing treatment
- Requirement for oxygen therapy
- Cor pulmonale or right ventricular hypertrophy
- Episodes of acute respiratory failure
- Severe restriction in activities of daily living
CFR: DC 6721: Tuberculosis, pulmonary, chronic, far advanced, inactive. M21-1 Example: Far advanced inactive TB rated 100% from date of inactivity, 50% two years later, 30% four years after inactivity date per staged reduction schedule.
50% Inactive (arrested) pulmonary TB with far-advanced lesion hi ...
Inactive (arrested) pulmonary TB with far-advanced lesion history, two years after the date of inactivity under the staged reduction schedule per 38 CFR 4.88b. Also applicable to inactive TB with moderately advanced residual damage that produces significant but not total functional impairment as rated under the residual respiratory conditions framework.
Key Symptoms
- FEV1 in the 40-55% of predicted range
- Persistent dyspnea on moderate exertion
- Requirement for bronchodilators or other respiratory medications
- Chronic productive cough with significant sputum production
- Moderate restriction in daily activities due to breathlessness
- Ongoing pulmonary hypertension without cor pulmonale
- Moderate radiographic residuals: scarring, fibrosis, calcification
CFR: M21-1 V.iii.4.B.3: Far advanced inactive TB reduced to 50% two years after date of inactivity. M21-1 Example 3: Reduction to 50% effective date of last payment at expiration of due process period.
30% Inactive (arrested) pulmonary TB with far-advanced lesion hi ...
Inactive (arrested) pulmonary TB with far-advanced lesion history, four years after the date of inactivity under the staged reduction schedule per 38 CFR 4.88b. Also applicable to inactive TB residuals with mild-to-moderate functional impairment rated under associated respiratory diagnostic codes.
Key Symptoms
- FEV1 in the 56-70% of predicted range
- Dyspnea on significant exertion but not at rest or with mild activity
- Mild chronic cough
- Residual pleural thickening or scarring on imaging
- Mild limitation in physical activities
- Occasional use of rescue inhalers
CFR: M21-1 V.iii.4.B.3: Far advanced inactive TB reduced to 30% four years after date of inactivity. M21-1 Example 4: Staged reduction to 30% four years after date of reinstatement following reexamination.
0% Inactive TB with minimal or no residual functional impairmen ...
Inactive TB with minimal or no residual functional impairment. Spirometry near normal, no significant respiratory symptoms, no complications, and no ongoing treatment requirement. However, a 0% rating still establishes service connection, preserving eligibility for future increases if condition worsens or complications develop.
Key Symptoms
- FEV1 and FVC greater than 70% of predicted
- No dyspnea at rest or with normal activity
- No requirement for respiratory medications
- Stable imaging with only minor calcifications or scarring
- No constitutional symptoms
- No complications such as pulmonary hypertension or cor pulmonale
CFR: Residual respiratory ratings under 38 CFR 4.97; 0% rating applies when TB is inactive with no compensable residuals. Service connection should still be established.
How to Describe Your Symptoms
Dyspnea (Shortness of Breath)
How to describe:
Quantify your breathlessness in concrete functional terms. Describe specific activities you can no longer perform or that require you to stop and rest. Use the MRC Dyspnea Scale as a framework: Can you walk on level ground without stopping? Do you need to stop after 100 yards? Are you breathless getting dressed? Specify whether breathlessness is worse in cold weather, humidity, or after respiratory infections.
Worst-day example:
“On my worst days, I cannot walk from my bedroom to the kitchen without stopping to catch my breath. I have to sit on the edge of the bed for several minutes after getting dressed before I can continue. I canceled a family outing last month because I knew I could not keep up with walking across a parking lot.”
What the examiner listens for:
The examiner is assessing whether dyspnea limits occupational activities, whether it occurs at rest versus only with exertion, and whether it correlates with spirometry findings. Specific functional limitations are more persuasive than general statements of 'shortness of breath.'
Understatements to avoid:
Avoid saying 'I get a little winded' - instead say 'I become significantly short of breath and must rest after [specific distance or activity].' Do not minimize symptoms to appear stoic.
Chronic Cough and Sputum Production
How to describe:
Describe the frequency (times per day, times per week), character (dry vs. productive), color and amount of sputum, and whether coughing is worse at certain times of day or triggered by specific factors. Note any episodes of hemoptysis (coughing up blood) with dates and amount.
Worst-day example:
“On my worst days, I cough for extended periods in the morning - sometimes for 30 to 45 minutes - bringing up thick yellow-green sputum. The coughing wakes me from sleep at least three nights per week. I have had two episodes this year where I coughed up blood, which required urgent care visits.”
What the examiner listens for:
Frequency, severity, impact on sleep and daily activities, any hemoptysis, and whether the cough is productive versus dry. Hemoptysis is particularly significant and should be documented with specific dates and amounts.
Understatements to avoid:
Do not omit hemoptysis even if it seems minor - any episode of blood in sputum is clinically significant for TB residuals. Do not say 'I just have a normal cough' without quantifying its impact on your sleep, work, and daily life.
Fatigue and Constitutional Symptoms
How to describe:
Describe fatigue in terms of its impact on your ability to complete daily tasks, work, or maintain social activities. Distinguish fatigue from ordinary tiredness - explain that it does not resolve with rest. Note any persistent low-grade fevers, night sweats, or unintentional weight loss if active or recently active.
Worst-day example:
“On my worst days, I wake up exhausted after 8 to 9 hours of sleep, often with soaking night sweats. By noon I have no energy to complete basic household tasks. I have lost 15 pounds in the past six months without trying. I had to stop working my part-time job because I could not sustain even light activity for a full shift.”
What the examiner listens for:
Whether fatigue is severe enough to impact occupational functioning, whether night sweats and weight loss suggest ongoing or partially treated disease, and the overall impairment of health caused by the condition.
Understatements to avoid:
Do not attribute fatigue solely to age or unrelated factors during the exam. Accurately connect fatigue to your TB condition and its treatment course.
Chest Pain and Pleuritic Symptoms
How to describe:
Describe whether chest pain is sharp, dull, or pressure-like, whether it is pleuritic (worsens with deep breathing or coughing), and its location. Note whether pain limits your ability to take deep breaths, exercise, or sleep comfortably. Describe any history of pleural effusion, pleuritis, or empyema.
Worst-day example:
“On my worst days, any deep breath causes a sharp stabbing pain on my left side that makes me afraid to breathe deeply. I have to sleep sitting up because lying flat increases the pain. I cannot exercise at all because the combination of breathing harder and chest pain is unbearable.”
What the examiner listens for:
Evidence of pleural involvement (rated separately as tuberculous pleurisy), whether chest pain limits respiratory effort during pulmonary function testing, and the overall functional impact on daily living.
Understatements to avoid:
Do not minimize chest pain - it has both direct rating implications (tuberculous pleurisy) and impacts how accurately spirometry results capture your true limitations.
Non-Pulmonary TB Manifestations
How to describe:
If you have had or currently have non-pulmonary TB involvement (skeletal, genitourinary, gastrointestinal, meningitis, lymphadenitis, ocular, cutaneous, or laryngeal), describe each manifestation separately with specific symptoms, functional limitations, and treatment history. These are rated separately from pulmonary TB.
Worst-day example:
“For skeletal TB: On my worst days my back pain from spinal TB is an 8 out of 10. I cannot stand for more than 10 minutes, I cannot lift anything over 5 pounds, and I need a cane to walk. For genitourinary TB: I experience severe pelvic pain on my worst days, urinary frequency every 30 minutes, and I have had multiple procedures for ureteral strictures.”
What the examiner listens for:
Each non-pulmonary site of involvement may result in a separate rating. The examiner will check specific DBQ fields for each type. Accurate and detailed reporting of each site's symptoms maximizes the completeness of the DBQ.
Understatements to avoid:
Do not fail to mention non-pulmonary involvement just because the exam is labeled 'pulmonary.' The DBQ covers all TB manifestations. Each system affected should be described in detail.
Treatment Burden and Medication Side Effects
How to describe:
Describe the full anti-TB treatment regimen you were placed on, how long it lasted, any adverse effects (hepatotoxicity from isoniazid, optic neuritis from ethambutol, peripheral neuropathy from isoniazid, hearing loss from streptomycin), and whether you required drug modifications. Treatment burden itself informs the severity narrative.
Worst-day example:
“During my 9-month RIPE therapy course I developed peripheral neuropathy in both feet that persists today. I also had an episode of drug-induced hepatitis that required me to stop all medications for three weeks. The neuropathy remains severe enough that I cannot stand on hard floors for more than 20 minutes.”
What the examiner listens for:
Completeness of treatment, drug resistance requiring second-line agents, treatment complications that resulted in additional diagnoses, and ongoing effects of medications that are ratable as secondary conditions.
Understatements to avoid:
Do not dismiss medication side effects as 'already over' if they caused permanent damage. Peripheral neuropathy from isoniazid, for example, may be separately ratable as a secondary service-connected condition.
Common Mistakes to Avoid
Reporting only current symptoms without describing worst-day functioning
VA ratings are based on the overall picture of disability including worst-day severity, not just how you feel on exam day. M21-1 guidance and case law support using the full range of your symptom experience.
Instead: Explicitly state when the examiner asks about symptoms: 'On my average day I experience X, but on my worst days - which occur about [frequency] - I experience Y.' Bring a written symptom diary documenting bad days.
Impact: All levels - critical for distinguishing 30% vs. 50% vs. 100%
Failing to disclose non-pulmonary TB manifestations during a pulmonary-focused exam
The Tuberculosis DBQ covers all sites of TB involvement. Each non-pulmonary manifestation may result in a separate, additional rating. Failing to report them means the DBQ remains incomplete and those conditions may go unrated.
Instead: Before the exam, prepare a written list of all past and current TB manifestations by body site. Hand it to the examiner and ask that each site be documented in the appropriate DBQ section.
Impact: Affects total combined disability rating - potentially significant
Stopping short of maximum effort during spirometry to 'be safe' or avoid discomfort
Submaximal effort produces artificially elevated spirometry values that do not reflect true functional impairment, potentially resulting in a lower rating that does not accurately capture disability.
Instead: Give your honest maximum effort. If discomfort or coughing limits your effort, tell the technician and examiner - this limitation is itself important clinical information that should be documented.
Impact: Critical for 30% vs. 60% vs. 100% under residual respiratory ratings
Not mentioning that far-advanced lesions were documented at any point during the disease
Under 38 CFR 4.88b, a history of far-advanced lesions triggers the staged reduction schedule (100% - 50% - 30%) even after the disease becomes inactive. If the examiner is unaware of prior far-advanced disease, this protection may be missed.
Instead: Bring copies of all prior chest imaging reports or radiology reads that documented far-advanced, extensive, or bilateral involvement. Specifically point out these findings to the examiner.
Impact: Directly determines eligibility for 100% (inactive) vs. lower ratings
Describing functional limitations in vague terms without specific examples
The examiner must document concrete functional impairment in the DBQ narrative fields. Vague statements like 'I feel bad' or 'it affects my life' do not give the examiner sufficient detail to accurately populate functional limitation fields.
Instead: Prepare specific examples: distances walked before stopping, household tasks you can no longer complete, lost employment, missed appointments, inability to perform hobbies. Quantify everything possible.
Impact: Critical for occupational and industrial impairment determinations
Assuming TB is automatically service-connected without providing nexus information
Service connection requires a nexus between active duty service and the TB diagnosis. This may be direct SC, presumptive SC under 38 CFR 3.309, or secondary SC from another service-connected condition. Providing this information helps the examiner document it correctly.
Instead: Be prepared to explain exactly when, where, and how TB was contracted or diagnosed in relation to military service. Bring any relevant service treatment records, separation documents, or buddy statements.
Impact: Foundational - affects initial grant of service connection
Not requesting a copy of the completed DBQ before leaving the exam
You have the right to request a copy of the DBQ. Reviewing it allows you to identify any factual errors, omissions, or mischaracterizations that could negatively impact your rating decision.
Instead: At the end of the exam, politely ask the examiner for a copy of the completed DBQ or ask how you can obtain one through VA. You can also request it through your VSO or via a FOIA/Privacy Act request.
Impact: All levels
Prep Checklist
Before Your Exam
Day Of
During the Exam
After the Exam
Your Rights During a C&P Exam
- You have the right to be examined by a qualified physician - for tuberculosis, this should be a Pulmonologist or Infectious Disease Physician. If the examiner lacks appropriate expertise, you may request a more qualified examiner through your VSO.
- You have the right to request a copy of the completed DBQ and all examination reports associated with your claim.
- In most states, you have the right to record your C&P examination. Check your specific state's recording consent laws. Notify the examiner at the start of the appointment that you will be recording.
- You have the right to submit a personal statement, buddy statements (VA Form 21-10210), and private medical opinions to supplement or rebut the C&P examination findings.
- You have the right to request a new C&P examination if the original examination was inadequate, the examiner failed to review relevant records, or the DBQ contains factual errors. This request should be submitted through your VSO or directly to the VA Regional Office handling your claim.
- You have the right to a Duty to Assist - VA is obligated to assist you in obtaining relevant records, scheduling examinations, and developing your claim. If VA failed to obtain records you identified, this may constitute a Duty to Assist error.
- You have the right to appeal an unfavorable rating decision through the Supplemental Claim, Higher-Level Review, or Board of Veterans' Appeals lanes under the Appeals Modernization Act (AMA).
- You have the right to bring a VSO representative, accredited claims agent, or VA-accredited attorney with you to the C&P examination as a witness and advocate.
- Under 38 CFR 4.88b, if your pulmonary TB was ever far advanced, you have the right to the staged reduction schedule (100% for two years after inactivity, then 50%, then 30%). VA cannot reduce your rating below this schedule without documented clinical improvement.
- You have the right to a rating that reflects your worst-day symptoms, not just your status on the day of the examination. If the examiner only documents your presentation on exam day, you have the right to submit evidence of your typical worst-day functioning.
- You have the right to separate ratings for each distinct non-pulmonary manifestation of tuberculosis (skeletal, genitourinary, meningitis, etc.) in addition to the pulmonary rating. Do not accept a single rating if multiple body systems were affected.
- You have the right to have all relevant VA records, service treatment records, and private medical evidence reviewed by the examiner before or during the examination. If the examiner states they did not review your records, document this and report it to your VSO.
Related Conditions
- Chronic Obstructive Pulmonary Disease (COPD) / Emphysema TB related lung destruction can cause obstructive lung disease patterns, including emphysema and COPD. If spirometry shows an obstructive pattern secondary to pulmonary TB, a separate rating under DC 6600 (Bronchitis, chronic) or DC 6604 (Emphysema) may be warranted in addition to the TB rating.
- Pulmonary Hypertension Chronic pulmonary TB and extensive lung fibrosis can elevate pulmonary arterial pressure, resulting in pulmonary hypertension. This complication is directly documented in the TB DBQ and may support higher rating levels or a separate secondary service connected rating under DC 7008.
- Cor Pulmonale / Right Heart Failure Severe pulmonary TB with extensive fibrosis or pulmonary hypertension can cause right ventricular hypertrophy and cor pulmonale. This cardiac complication is documented in the TB DBQ (fields 57 and 56) and may be separately ratable or may elevate the overall respiratory rating.
- Tuberculous Pleurisy / Pleural Scarring Pleural involvement with TB is separately documented in the DBQ under DC 7710 (Pleurisy, TB, active) or as inactive pleural scarring. Pleural thickening and restrictive physiology from pleural disease may be separately ratable as a residual condition.
- Peripheral Neuropathy (Isoniazid-induced) Isoniazid (INH), a first line anti TB medication, commonly causes peripheral neuropathy through pyridoxine (Vitamin B6) depletion. If you developed peripheral neuropathy during or after TB treatment, it may be ratable as a secondary service connected condition caused by treatment for service connected TB.
- Drug-Induced Hepatitis / Liver Disease Multiple first line TB medications (isoniazid, rifampin, pyrazinamide) are hepatotoxic and can cause drug induced hepatitis. If you developed liver disease during TB treatment, it may qualify as a secondary service connected condition. Symptoms include jaundice, right upper quadrant pain, and elevated liver enzymes.
- Skeletal Tuberculosis (Pott's Disease / TB Arthritis) TB infection of the spine (Pott's Disease) or other joints is a direct manifestation of tuberculosis rated separately under the musculoskeletal diagnostic codes. If you have spinal TB or TB arthritis, ensure this is documented in the DBQ under skeletal TB and rated under the appropriate DC with full DeLuca factor analysis for ROM and functional loss.
- Genitourinary Tuberculosis TB can infect the kidneys, ureters, bladder, and reproductive organs. Genitourinary TB is documented separately in the DBQ and rated under genitourinary diagnostic codes. Residuals may include ureteral strictures, renal insufficiency, bladder scarring, and infertility.
- Tuberculous Meningitis / CNS Tuberculosis TB infection of the meninges or central nervous system is a serious manifestation with significant neurological residuals including headaches, cognitive impairment, cranial nerve palsies, and hearing loss. Rated separately under neurological diagnostic codes in addition to TB rating.
- Depression and Anxiety (Secondary to Chronic Illness) Veterans with chronic TB or severe TB residuals frequently develop depression, anxiety, or PTSD related to the prolonged nature of the illness, its stigma, treatment burden, functional limitations, and social isolation. These mental health conditions may be ratable as secondary to service connected TB.
Get Personalized C&P Exam Preparation
Upload your medical records for AI-powered prep that maps YOUR symptoms to the exact DBQ fields your examiner will evaluate.
This C&P exam preparation guide is for educational purposes only and does not constitute legal, medical, or claims advice. Always consult with a qualified Veterans Service Organization (VSO) representative or VA-accredited attorney for guidance specific to your claim. Never exaggerate, minimize, or fabricate symptoms during a C&P examination.